Morgan Stanley
BBP icon

Morgan Stanley’s Virtus Biotech ETF BBP Stock Holding History

Morgan Stanley’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
11,370
-4,641
-29% -$404K ﹤0.01% 5170
2026
Q1 		$1.33M Buy
16,011
+569
+4% +$46.8K ﹤0.01% 5002
2025
Q4 		$1.23M Buy
15,442
+1,071
+7% +$81.3K ﹤0.01% 5073
2025
Q3 		$1.01M Sell
14,371
-806
-5% -$52.8K ﹤0.01% 5176
2025
Q2 		$884K Buy
15,177
+6,156
+68% +$348K ﹤0.01% 5166
2025
Q1 		$529K Buy
9,021
+67
+0.7% +$4.11K ﹤0.01% 5301
2024
Q4 		$537K Buy
8,954
+200
+2% +$12.6K ﹤0.01% 5389
2024
Q3 		$550K Buy
8,754
+752
+9% +$46.8K ﹤0.01% 5356
2024
Q2 		$470K Sell
8,002
-2,435
-23% -$136K ﹤0.01% 5318
2024
Q1 		$591K Sell
10,437
-2,879
-22% -$168K ﹤0.01% 5234
2023
Q4 		$774K Buy
13,316
+11,050
+488% +$559K ﹤0.01% 5423
2023
Q3 		$113K Sell
2,266
-40,618
-95% -$2.14M ﹤0.01% 5832
2023
Q2 		$2.26M Buy
42,884
+25,385
+145% +$1.33M ﹤0.01% 4353
2023
Q1 		$862K Buy
17,499
+6,040
+53% +$303K ﹤0.01% 4940
2022
Q4 		$565K Buy
11,459
+8,927
+353% +$427K ﹤0.01% 5176
2022
Q3 		$115K Buy
2,532
+558
+28% +$25.8K ﹤0.01% 6008
2022
Q2 		$81K Sell
1,974
-100
-5% -$3.97K ﹤0.01% 6382
2022
Q1 		$90K Sell
2,074
-20
-1% -$860 ﹤0.01% 6373
2021
Q4 		$102K Buy
2,094
+18
+0.9% +$895 ﹤0.01% 6425
2021
Q3 		$106K Buy
2,076
+3
+0.1% +$155 ﹤0.01% 6338
2021
Q2 		$110K Buy
2,073
+5
+0.2% +$264 ﹤0.01% 6308
2021
Q1 		$108K Buy
2,068
+22
+1% +$1.23K ﹤0.01% 5963
2020
Q4 		$109K Buy
2,046
+100
+5% +$5.13K ﹤0.01% 5872
2020
Q3 		$93K Buy
1,946
+85
+5% +$3.96K ﹤0.01% 5458
2020
Q2 		$88K Buy
1,861
+18
+1% +$804 ﹤0.01% 5465
2020
Q1 		$69K Sell
1,843
-1
-0.1% -$41 ﹤0.01% 5338
2019
Q4 		$80K Sell
1,844
-287
-13% -$11.5K ﹤0.01% 5719
2019
Q3 		$77K Sell
2,131
-73
-3% -$2.8K ﹤0.01% 5535
2019
Q2 		$90K Buy
2,204
+171
+8% +$7.04K ﹤0.01% 5376
2019
Q1 		$91K Sell
2,033
-206
-9% -$8.63K ﹤0.01% 5429
2018
Q4 		$78K Sell
2,239
-8,603
-79% -$327K ﹤0.01% 5631
2018
Q3 		$493K Buy
10,842
+5,150
+90% +$230K ﹤0.01% 5014
2018
Q2 		$250K Buy
5,692
+5,580
+4,982% +$237K ﹤0.01% 5458
2018
Q1 		$4K Buy
112
+12
+12% +$505 ﹤0.01% 6419
2017
Q4 		$4K Hold
100
– – ﹤0.01% 6357
2017
Q3 		$4K Hold
100
– – ﹤0.01% 6317
2017
Q2 		$4K Sell
100
-35
-26% -$1.31K ﹤0.01% 6377
2017
Q1 		$5K Buy
135
+35
+35% +$1.28K ﹤0.01% 6349
2016
Q4 		$3K Hold
100
– – ﹤0.01% 6334
2016
Q3 		$3K Hold
100
– – ﹤0.01% 6313
2016
Q2 		$3K Hold
100
– – ﹤0.01% 6294
2016
Q1 		$2K Hold
100
– – ﹤0.01% 6394
2015
Q4 		$3K Hold
100
– – ﹤0.01% 6452
2015
Q3 		$3K Buy
+100
New +$3.38K ﹤0.01% 6445

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley's BBP Position: Q2 2026 in Review

Morgan Stanley reduced its Virtus Biotech ETF (BBP) stake by 29% in Q2 2026, selling an estimated $404K and leaving 11,370 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #5170.

Morgan Stanley first reported a position in BBP in Q3 2015 and has held it in 44 quarters since. The position peaked at $2.26M in Q2 2023. 26 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • Morgan Stanley held 11,370 shares of Virtus Biotech ETF worth $1.09M as of Q2 2026.
  • Morgan Stanley sold 4,641 Virtus Biotech ETF shares in Q2 2026, an estimated $404K.
  • Virtus Biotech ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5170 holding.
  • Morgan Stanley first reported a position in Virtus Biotech ETF in Q3 2015 and has held it in 44 quarters since.
  • Morgan Stanley's Virtus Biotech ETF position peaked at $2.26M in Q2 2023.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.